Correlation Between Cisco Systems and Acasti Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cisco Systems and Acasti Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cisco Systems and Acasti Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cisco Systems and Acasti Pharma, you can compare the effects of market volatilities on Cisco Systems and Acasti Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cisco Systems with a short position of Acasti Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cisco Systems and Acasti Pharma.

Diversification Opportunities for Cisco Systems and Acasti Pharma

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cisco and Acasti is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Cisco Systems and Acasti Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acasti Pharma and Cisco Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cisco Systems are associated (or correlated) with Acasti Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acasti Pharma has no effect on the direction of Cisco Systems i.e., Cisco Systems and Acasti Pharma go up and down completely randomly.

Pair Corralation between Cisco Systems and Acasti Pharma

Given the investment horizon of 90 days Cisco Systems is expected to generate 0.35 times more return on investment than Acasti Pharma. However, Cisco Systems is 2.9 times less risky than Acasti Pharma. It trades about 0.1 of its potential returns per unit of risk. Acasti Pharma is currently generating about 0.01 per unit of risk. If you would invest  4,778  in Cisco Systems on September 1, 2024 and sell it today you would earn a total of  1,143  from holding Cisco Systems or generate 23.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy87.77%
ValuesDaily Returns

Cisco Systems  vs.  Acasti Pharma

 Performance 
       Timeline  
Cisco Systems 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Cisco Systems are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting fundamental indicators, Cisco Systems displayed solid returns over the last few months and may actually be approaching a breakup point.
Acasti Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Good
Over the last 90 days Acasti Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively weak basic indicators, Acasti Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Cisco Systems and Acasti Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cisco Systems and Acasti Pharma

The main advantage of trading using opposite Cisco Systems and Acasti Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cisco Systems position performs unexpectedly, Acasti Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will offset losses from the drop in Acasti Pharma's long position.
The idea behind Cisco Systems and Acasti Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges